THE CRITICAL PATH INSTITUTE
Federal contract awards won by THE CRITICAL PATH INSTITUTE (UEI KAEPADMRKHD3), 2018–2024 — public record from USAspending.
Showing awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
5
awards
1
expiring in 12 months
1
agency
Teaming snapshot
primes 1 sub.
From subcontract reports primes file with USAspending/FSRS.
Where their reported work happens
| State | Reported subawards |
|---|---|
| NC | 1 |
Place of performance on subcontract reports filed with USAspending/FSRS.
Category award history
2 category awards to a new vendor (same agency and NAICS code, not this contract's own history) — latest: THE EMMES COMPANY, LLC took Department of Health and Human Services 541715 work from THE CRITICAL PATH INSTITUTE (Sep 29, 2025).
Agencies buying from THE CRITICAL PATH INSTITUTE
What THE CRITICAL PATH INSTITUTE has provided
Awards
BAA FOR DEVELOPMENT OF DRUG DEVELOPMENT TOOLS FOR ADTKD
Department of Health and Human Services · $2,774,844 · Aug 16, 2024
BAA EETWP #63: A STANDARDIZED FRAMEWORK TO SUPPORT FDA QUALIFICATION OF COMPLEX IN VITRO MODELS FOR USE IN REGULATORY SUBMISSIONS.
Department of Health and Human Services · $1,672,008 · Sep 26, 2022
PMWP 108 MODEL-INFORMED DRUG DEVELOPMENT (MIDD) IN THE EVALUATION AND DEVELOPMENT OF NEUROLOGICAL DRUG PRODUCTS
Department of Health and Human Services · $1,128,848 · Sep 29, 2020
BROAD AGENCY ANNOUNCEMENT (BAA) CONTRACT -- DEVELOPING NOVEL CLINICAL OUTCOME ASSESSMENTS FOR PEDIATRIC ASTHMA TO FACILITATE INNOVATIVE PATIENT-FOCUSED DRUG DEVELOPMENT AND AID REGULATORY DECISION MAKING
Department of Health and Human Services · $2,739,757 · Sep 30, 2019
IGF::OT::IGF - DEVELOPING NOVEL KIDNEY TRANSPLANT DRUG DEVELOPMENT TOOLS TO ENHANCE REGULATORY DECISION MAKING AND ENABLE INNOVATION IN MEDICAL PRODUCT DEVELOPMENT
Department of Health and Human Services · $1,594,872 · Sep 19, 2018